Dr C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher and educator who pioneered our understanding of the "open artery hypothesis" as well our understanding of the importance of restoring flow downstream in the capillary bed in the "open microvasculature hypothesis" in heart attack. Gibson has been a leading investigator in trials of thrombolytic agents, glycoprotein 2b3a inhibitor agents, thienopyridines, factor Xa inhibitors, lipid lowering agents and new devices. Gibson was named one of the world's most widely published and cited scientists of past decade in 2014 by Thomson Reuters.
7515 Main Street,
Suite 195, Houston, Texas 77030, United States
Monday to Friday 8am - 6pm
imaware™ provides laboratory testing for wellness monitoring, informational, and educational use.
*Our tests are not intended to diagnose any conditions - only your healthcare provider can make that determination.